Odyssey Health, Inc., a medical company, focuses on the development and commercialization of medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and ONP -001 and ONP -002 neurosteroid drug compounds to treat concussions and rare brain disorders. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was incorporated in 2014 and is based in Las Vegas, Nevada.
Stock data | 2023 | Change |
---|---|---|
Price | $0.031 | N/A |
Market Cap | $2.56M | N/A |
Shares Outstanding | 82.68M | -7.10% |
Employees | 6.00 | N/A |
Shareholder Equity | -6.16M | 32.57% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -0.44 | N/A |
P/B Ratio | -0.42 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.9616 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $0 | N/A |
Earnings | -$5.92M | N/A |
EPS | -0.07 | N/A |
Earnings Yield | -2.26 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $455.79K | N/A |
Cash on Hand | $36.87K | N/A |
Debt to Equity | -1.0740 | -4.33% |
Current Ratio | 0.0614 | -39.20% |